- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02333227
Saving Lives at Birth: Primary Prevention of Periodontal Disease in Relation to Preterm Birth in Malawi (PPaX)
Saving Lives at Birth: Primary Prevention of Periodontal Disease in Relation to Preterm Birth in Malawi (Prevention of Prematurity and Xylitol)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Significance and Impact: Adverse birth outcomes related to the length of gestation (preterm birth) are recognized as one of the most significant disorders in maternal-child health at a global scale. In the developed world, the preterm birth rate approximates 7%. In Malawi, the investigators have recently demonstrated that this rate more than triples to approximate 26.1%. Of the 4 million newborn deaths annually, nearly 1/3 (27%) are directly attributable to prematurity with another 36% secondary to related opportunistic infections (sepsis, pneumonia, gastrointestinal). 75% of the 4 million deaths occur within the first week of life, with the vast majority occurring in the first 48 hours. For those that do survive, there are persistent and lifelong risks due to stunted growth, chronic infection, retinopathy of prematurity, and bronchopulmonary dysplasia. The link between maternal oral health (periodontal disease in particular) and risk of preterm birth has been demonstrated across all populations (rural and urban, in both industrialized and developing regions) studied to date. However, in multiple randomized controlled trials treatment of active periodontal disease with scaling and planning during pregnancy has failed to demonstrate a significant benefit in preventing preterm birth.
Why would maternal oral health impact preterm birth? In rodents, subcutaneous inoculations with periodontal pathogens cause dose-dependent decreases in pup weights, and elicit inflammatory responses that can trigger preterm birth when present in amniotic fluid. Periodontitis (defined as a destructive inflammation of the periodontium) has a prevalence of 30% or greater in women of child bearing age. By definition, it involves microbial infiltration of the periodontium, which stimulates a chronic inflammatory response, recurrent bacteremia, and the production of cytokines and prostaglandins which trigger risk of preterm birth. It is the same production of prostaglandins which are felt to mediate the risk of preterm birth. So if the investigators know that there is biologic evidence that periodontitis is related to preterm birth, but treating active periodontitis does not reduce these morbidities, is it possible that preventing periodontitis might prevent preterm birth and low birth weight? If so, what are the least expensive efficacious preventative measures? The investigators' overarching hypothesis is that comprehensive primary preterm birth prevention, inclusive of maternal oral health with xylitol chewing gum (the intervention), will reduce the rate of periodontal disease and caries, preterm birth prevalence, and neonatal mortality.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Baylor College of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Enrollment at <20 weeks gestation by best obstetrical estimate, or
- Enrollment post partum with an anticipated next pregnancy within 18 months, or
- Enrollment preconception with an anticipated pregnancy within 18 months (preconception); and
- Cognitively aware enough to participate in the study
- >18 years of age (in Malawi, constitutes a legal adult and capacity to consent for study)
- Willing to participate in the study
- Willing to undergo at least two periodontal exams
- Willing to chew 1 piece of xylitol gum for 10 minutes after the morning and evening meal (intervention sites)
- Anticipating to remain within the region for 18 months
Exclusion Criteria:
- >20 weeks gestation by best obstetrical estimate
- Post partum and not anticipating another pregnancy within 18 months
- Preconception and not anticipating another pregnancy within 18 months
- Not cognitively aware enough to participate in the study
- Not willing to undergo at least two periodontal exams
- <18 years of age
- Not willing to chew 1 piece of xylitol gum for 10 minutes after the morning and evening meal (intervention sites)
- Anticipating a move outside of the region within 18 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Cluster of sites not receiving xylitol gum.
This is a cluster randomized trial, whereby 4 sites will not receive the intervention of xylitol gum in the prepregnancy and early pregnancy interval.
|
|
Experimental: Xylitol
Cluster of sites receiving xylitol gum.
|
This is a cluster randomized trial, whereby 4 sites will receive the intervention of xylitol gum in the prepregnancy and early pregnancy interval.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of Preterm Birth
Time Frame: Conception to date of delivery, <37 weeks gestation
|
This is a co-primary outcome: Measure rate of preterm birth <37 weeks gestation, as defined by best obstetrical estimate based upon last menstrual period correlated with fundal height at entry to prenatal care or ultrasound, when available; all sites have access to referral for ultrasound.
|
Conception to date of delivery, <37 weeks gestation
|
Number of Infants <2500 Grams
Time Frame: Date of delivery to 1 week postnatal
|
This is a co-primary outcome: Measured weight at delivery to determine the rate of <2500 gram infants.
|
Date of delivery to 1 week postnatal
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Infants With Adverse Neonatal Composite Morbidity and Mortality
Time Frame: Date of delivery to 28 days postnatal
|
Additive or singular composite neonatal morbidity up to 28 days of age.
Composite neonatal morbidity and mortality outcomes are defined as: neonatal death, miscarriage <28 weeks, stillbirth (fresh or macerated), neonatal sepsis, neonatal respiratory distress, neonatal seizures, feeding problems, fever, hypothermia, Apgar score <7 at 5 minutes after birth, referral to other hospital or neonatal intensive care unit (NICU)
|
Date of delivery to 28 days postnatal
|
Number of Participants With Periodontal Disease
Time Frame: During pregnancy, up to 2 dental visits performed during pregnancy (approximately 37-40 weeks if term) to evaluate dental outcomes
|
We will measure the prevalence of periodontal disease among gravidae.
We will use standardized World Health Organization (WHO) oral health forms and disease scoring.
|
During pregnancy, up to 2 dental visits performed during pregnancy (approximately 37-40 weeks if term) to evaluate dental outcomes
|
Number of Participants With Dental Caries
Time Frame: During pregnancy, up to 2 dental visits performed during pregnancy (approximately 37-40 weeks if term) to evaluate dental outcomes
|
We will measure the prevalence of dental caries among gravidae.
We will use standardized World Health Organization (WHO) oral health forms and disease scoring.
|
During pregnancy, up to 2 dental visits performed during pregnancy (approximately 37-40 weeks if term) to evaluate dental outcomes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kjersti Aagaard, M.D., Baylor College of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NHSRC # 1030
- H-35933 (Other Identifier: Baylor College of Medicine)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Birth
-
e-Bio CorpRecruitingPreterm Labor | PreTerm Birth | Preterm Labor With Delivery NosUnited States
-
Thomas Jefferson UniversityCompleted
-
Federico II UniversityRecruiting
-
University of OxfordShoklo Malaria Research UnitCompleted
-
Chelsea and Westminster NHS Foundation TrustSPD Development Company Limited; Borne CharityRecruitingPreterm Birth | Preterm Labor | Preterm Birth Complication | Preterm Premature Rupture of Membrane | Preterm PregnancyUnited Kingdom
-
PreTeL, IncDuke University; University of RochesterRecruitingPreterm Birth | Threatened Preterm Labor | PreTerm LaborUnited States
-
Cairo UniversityCompleted
-
University of OklahomaCompletedPreTerm Birth | PreTerm NeonateUnited States
-
Eunice Kennedy Shriver National Institute of Child...CompletedPregnancy | Preterm Birth | Preterm LaborUnited States
-
University Hospital Inselspital, BerneAmniSure International LLCCompletedPreterm Birth | Preterm LabourSwitzerland
Clinical Trials on Xylitol gum
-
Baylor College of MedicineUniversity of Washington; Fogarty International Center of the National Institute... and other collaboratorsNot yet recruiting
-
Università degli Studi di SassariUniversity of MilanCompletedPeriodontal Diseases | Dental CariesItaly
-
Roquette Management (Shanghai) Co., Ltd.Kaunas University of Medicine; West China College of StomatologyCompletedRe-mineralizationChina
-
University of WashingtonRecruitingNeurodevelopmental Disorders | PrematurityMalawi
-
Universidad de CuencaRecruiting
-
Kuwait UniversityUniversity of Turku; University of MichiganCompleted
-
University of TorontoNot yet recruitingDental Caries | Dental Plaque | Periodontal Disease
-
Danderyd HospitalCompleted
-
The University of The West IndiesJ. Craig Venter InstituteCompletedHuman Microbiome
-
The University of Texas Health Science Center,...CONFADENT Oral Technology, Kiss Industries LLCCompletedPeriodontal Diseases | Gingivitis | Plaque, DentalUnited States